Objective: To assess, among clozapine users, the rates of monitoring, presence and treatment of metabolic syndrome and its components. Methods: A chart review was conducted of all clozapine users who were followed up in community mental health clinics at two Metro South Health Hospitals over a 1-year period. Metabolic syndrome was diagnosed according to the International Diabetes Federation criteria. Results: We included 251 clozapine users. Only 43.4% (109/251) had data collected for all five metabolic syndrome parameters. Among these people, 45.0% (49/109) met criteria for metabolic syndrome, while 61.2% (30/49) of those with metabolic syndrome were offered appropriate treatments. Correspondence with primary care providers occurred in onl...
Metabolic complications are commonly found in people treated with clozapine. Reviews on the manageme...
Approximately one percent (1%) of the South African population suffers from schizophrenia. Clozapine...
This project was designed to improve fidelity to ADA/APA metabolic monitoring guidelines for patient...
Objective : To study the prevalence of metabolic syndrome in patients receiving clozapine. Materials...
Objective: To describe the process and impact of a service-level intervention on metabolic monitorin...
Objective: This study aimed to determine the prevalence and predictors of metabolic syndrome in an o...
People who are diagnosed with treatment resistant schizophrenia (TRS) are likely to have clozapine a...
textabstractAbstract Metabolic syndrome during clozapine treatment Objective: To assess the prevalen...
Objectives: Cross-sectional studies indicate that clozapine is associated with unusually high rates ...
BACKGROUND: The efficacy of clozapine for the treatment of schizophrenia has been demonstrated. Howe...
Introduction: Data on effect of clozapine on metabolic syndrome in adolescent patients with psychosi...
This thesis concerns clozapine, an antipsychotic for patients with schizophrenia for whom other anti...
Objective: To document and measure various parameters and outcomes in patients prescribed clozapine ...
Patients receiving clozapine must undergo routine blood monitoring to screen for neutropenia, and to...
OBJECTIVES:: The primary objective of the study was to determine whether the Monitoring Outcomes of ...
Metabolic complications are commonly found in people treated with clozapine. Reviews on the manageme...
Approximately one percent (1%) of the South African population suffers from schizophrenia. Clozapine...
This project was designed to improve fidelity to ADA/APA metabolic monitoring guidelines for patient...
Objective : To study the prevalence of metabolic syndrome in patients receiving clozapine. Materials...
Objective: To describe the process and impact of a service-level intervention on metabolic monitorin...
Objective: This study aimed to determine the prevalence and predictors of metabolic syndrome in an o...
People who are diagnosed with treatment resistant schizophrenia (TRS) are likely to have clozapine a...
textabstractAbstract Metabolic syndrome during clozapine treatment Objective: To assess the prevalen...
Objectives: Cross-sectional studies indicate that clozapine is associated with unusually high rates ...
BACKGROUND: The efficacy of clozapine for the treatment of schizophrenia has been demonstrated. Howe...
Introduction: Data on effect of clozapine on metabolic syndrome in adolescent patients with psychosi...
This thesis concerns clozapine, an antipsychotic for patients with schizophrenia for whom other anti...
Objective: To document and measure various parameters and outcomes in patients prescribed clozapine ...
Patients receiving clozapine must undergo routine blood monitoring to screen for neutropenia, and to...
OBJECTIVES:: The primary objective of the study was to determine whether the Monitoring Outcomes of ...
Metabolic complications are commonly found in people treated with clozapine. Reviews on the manageme...
Approximately one percent (1%) of the South African population suffers from schizophrenia. Clozapine...
This project was designed to improve fidelity to ADA/APA metabolic monitoring guidelines for patient...